Abstract
Mouse studies indicate that the synthetic glucocorticoid dexamethasone (Dex) impairs the proliferation of granule neuron precursors in the cerebellum, which are transformed to medulloblastoma by activation of Sonic hedgehog (Shh) signaling. Here, we show that Dex treatment also inhibits Shh-induced tumor growth, enhancing the survival of tumor-prone transgenic mice. We found that Nmyc was specifically required in granule cells for Shh-induced tumorigenesis and that Dex acted to reduce Nmyc protein levels. Moreover, we found that Dex-induced destabilization of Nmyc is mediated by activation of glycogen synthase kinase 3beta, which targets Nmyc for proteasomal degradation. Together, our findings show that Dex antagonizes Shh signaling downstream of Smoothened in medulloblastoma.
Copyright 2010 AACR.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Brain Neoplasms / drug therapy*
-
Brain Neoplasms / metabolism
-
Brain Neoplasms / pathology
-
Dexamethasone / pharmacology*
-
Glycogen Synthase Kinase 3 / metabolism
-
Glycogen Synthase Kinase 3 beta
-
Hedgehog Proteins / antagonists & inhibitors
-
Hedgehog Proteins / metabolism*
-
Medulloblastoma / drug therapy*
-
Medulloblastoma / metabolism
-
Medulloblastoma / pathology
-
Mice
-
Mice, Transgenic
-
Phosphorylation
-
Protein Structure, Tertiary
-
Proto-Oncogene Proteins c-myc / antagonists & inhibitors*
-
Proto-Oncogene Proteins c-myc / metabolism
-
Signal Transduction
-
Tumor Cells, Cultured
Substances
-
Hedgehog Proteins
-
Proto-Oncogene Proteins c-myc
-
Dexamethasone
-
Glycogen Synthase Kinase 3 beta
-
Gsk3b protein, mouse
-
Glycogen Synthase Kinase 3